| Qtr | Est | Actual | +/− |
|---|---|---|---|
| Q1'26 | $0.95 | $1.99 | +108.9% |
| Q4'25 | $2.21 | $1.25 | -43.4% |
| Q4'24 | $-0.14 | $0.06 | +142.5% |
| Qtr | Est | Actual | +/− |
|---|---|---|---|
| Q1'26 | $1.1B | $1.2B | +2.7% |
| Q4'25 | $1.1B | $1.1B | -3.7% |
| Q4'24 | - | $593M | - |
Market Data
ALNY is currently trading at $293.45, giving ALNY a market cap of 41.54B and a P/E ratio of 953.4. Today's range spans $301.17–$318.44, with shares opening at $301.88 and moving up $0.00 (0.0%) from the prior close. DailyIQ's technical score sits at 32/100 (SELL) with a news sentiment reading of 61/100.
Over the past year ALNY has traded between $205.87 and $495.55 - the current price is +42.5% off the 52-week low and -40.8% from the high.
Macro sensitivity explains some of ALNY's bearish setup (32/100, SELL) - at 41.54B in Healthcare market cap, interest rate shifts, currency moves, or commodity price changes can create fundamental headwinds that compound the technical deterioration. Sentiment: bullish (61/100). Price: $293.45 (in the lower half of its 52-week range). The current P/E ratio stands at 953.4. Annual range: $205.87–$495.55. The question for investors is whether the macro driver is transient or structural - because the answer determines whether this is a tradeable dip or a deeper re-rating.
When a large-cap Healthcare name with 41.54B in capitalization prints a SELL signal (32/100) alongside bullish news sentiment (61/100), the risk isn't just price depreciation — it's the loss of institutional sponsorship that makes recovery harder. At $293.45 (in the lower half of its 52-week range in the $205.87–$495.55 range), the structural support levels are where that sponsorship question gets answered.
Most recent articles, ranked by recency (click to expand).
Sentiment gathered from recent headlines